Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dobbin

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
JMIR Research Protocols|September 29, 2020
Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled TrialJuliet Nabbuye Sekandi, Nicole Amara Onuoha, Esther Buregyeya, et al.
ERJ Open Research|April 14, 2020
Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort studyJuliet N Sekandi, Esther Buregyeya, Sarah Zalwango, et al.
Vaccine|February 5, 2025
Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC studyYang Ge, Andreas Handel, Philippe J Giabbanelli, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerationsKevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer|November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationGiuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agentsJanet E Dancey, Kevin K Dobbin, Susan Groshen, et al.
Journal of Molecular Histology|February 24, 2007
Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experienceA Kajdacsy-Balla, J M Geynisman, V Macias, et al.
Blood|February 9, 2010
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaRichard C Harvey, Charles G Mullighan, I-Ming Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarraysKevin K Dobbin, David G Beer, Matthew Meyerson, et al.
Blood|August 12, 2010
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeRichard C Harvey, Charles G Mullighan, Xuefei Wang, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
JMIR Research Protocols|September 29, 2020
Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled TrialJuliet Nabbuye Sekandi, Nicole Amara Onuoha, Esther Buregyeya, et al.
ERJ Open Research|April 14, 2020
Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort studyJuliet N Sekandi, Esther Buregyeya, Sarah Zalwango, et al.
Vaccine|February 5, 2025
Exploring bias due to below-limit-of-detection values in influenza vaccine antibody modeling: A case study and instructional guide for the CIVIC studyYang Ge, Andreas Handel, Philippe J Giabbanelli, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerationsKevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer|November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationGiuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agentsJanet E Dancey, Kevin K Dobbin, Susan Groshen, et al.
Journal of Molecular Histology|February 24, 2007
Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experienceA Kajdacsy-Balla, J M Geynisman, V Macias, et al.
Blood|February 9, 2010
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaRichard C Harvey, Charles G Mullighan, I-Ming Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarraysKevin K Dobbin, David G Beer, Matthew Meyerson, et al.
Blood|August 12, 2010
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeRichard C Harvey, Charles G Mullighan, Xuefei Wang, et al.
Pageof 6